Arie Belldegrun, M.D.
Board Member
UroGen Pharma Ltd. (URGN)Equibles does not estimate personal net worth.
Get an email with a short summary when UroGen Pharma Ltd. publishes a filing, an earnings call transcript or a press release.
Get URGN alertsAbout Arie Belldegrun, M.D.
Arie Belldegrun, M.D. is recorded as Board Member at UroGen Pharma Ltd. (URGN) since June 22, 2026. UroGen Pharma Ltd. reported in an 8-K filed June 23, 2026 that Arie Belldegrun, M.D. was appointed Director, effective June 22, 2026. UroGen Pharma Ltd. reported in an 8-K filed August 27, 2025 that Arie Belldegrun, M.D. was appointed director, effective August 26, 2025. UroGen Pharma Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at UroGen Pharma Ltd. includes Elizabeth Barrett (CEO and Board Member), Arie Belldegrun (Chairman and Board Member), Chris Degnan (CFO) and 7 others.
“The shareholders elected the following seven individuals to serve as directors until the Company’s next annual meeting of shareholders and until their successors are elected.”
“The shareholders elected the following seven individuals to serve as directors until the Company’s next annual meeting of shareholders and until their successors are elected.”
Affiliation history
-
Current
2026-06-22–present
Company network
Leadership on record at UroGen Pharma Ltd.
- Elizabeth Barrett CEO, Board Member
- Arie Belldegrun Chairman, Board Member
- Chris Degnan CFO
- Dong (Don) Kim CFO
- Stephen L. Mullennix COO
- Jason Smith General Counsel
- Christopher Degnan Chief Accounting Officer
- Arie Belldegrun, M.D., FACS Board Member
- Cynthia M. Butitta Board Member
- Daniel G. Wildman Board Member